Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vipin Kumar Sharma, Khomendra Kumar Sarwa & Bhaskar Mazumder. (2014) Fluidity enhancement: a critical factor for performance of liposomal transdermal drug delivery system. Journal of Liposome Research 24:2, pages 83-89.
Read now
Read now
Neil A Mabbott, Mark W Head, Christine F Farquhar & Janet R Fraser. (2001) The transmissible spongiform encephalopathies: pathogenic mechanisms and strategies for therapeutic intervention. Expert Opinion on Therapeutic Targets 5:5, pages 569-585.
Read now
Read now
Yechezkel Barenholz & Rivka Cohen. (1995) Rational design of amphiphile-based drug carriers and sterically stabilized carriers. Journal of Liposome Research 5:4, pages 905-932.
Read now
Read now
Articles from other publishers (27)
Daniele Fernanda Renzi, Laís de Almeida Campos, Eduardo Hösel Miranda, Rubiana Mara Mainardes, Wolf-Rainer Abraham, Diana Fortkamp Grigoletto & Najeh Maissar Khalil. (2021) Nanoparticles as a Tool for Broadening Antifungal Activities. Current Medicinal Chemistry 28:9, pages 1841-1873.
Crossref
Crossref
Aamir Jalil, Mulazim Hussain Asim, Iram Shahzadi, Momin Khan, Barbara Matuszczak & Andreas Bernkop-Schnürch. (2020) Thiolated PVP–Amphotericin B Complexes: An Innovative Approach toward Highly Mucoadhesive Gels for Mucosal Leishmaniasis Treatment. Biomacromolecules 21:9, pages 3658-3667.
Crossref
Crossref
Melanie A. Hutnick & Jonathan K. Pokorski. (2018) Polymeric Interventions for Microbial Infections: A Review. Molecular Pharmaceutics 15:8, pages 2910-2921.
Crossref
Crossref
Maraine Catarina Tadini, Ana Maria de Freitas Pinheiro, Daniel Blascke Carrão, Ana Luiza Scarano Aguillera Forte, Sofia Nikolaou, Anderson R.M. de Oliveira, Andresa Aparecida Berretta & Franciane Marquele-Oliveira. (2017) Method validation and nanoparticle characterization assays for an innovative amphothericin B formulation to reach increased stability and safety in infectious diseases. Journal of Pharmaceutical and Biomedical Analysis 145, pages 576-585.
Crossref
Crossref
Mohammad Asad, Pradyot Bhattacharya, Antara Banerjee & Nahid Ali. (2015) Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B. BMC Infectious Diseases 15:1.
Crossref
Crossref
Manuela Carvalheiro, M. Alexandra Esteves, David Santos-Mateus, Rui M. Lopes, M. Armanda Rodrigues, Carla V. Eleutério, Effie Scoulica, Gabriela Santos-Gomes & M. Eugénia M. Cruz. (2015) Hemisynthetic trifluralin analogues incorporated in liposomes for the treatment of leishmanial infections. European Journal of Pharmaceutics and Biopharmaceutics 93, pages 346-352.
Crossref
Crossref
Andreas Zumbuehl, Pasquale Stano, Marc Sohrmann, Mathias Peter, Peter Walde & Erick M. Carreira. (2007) A novel strategy for bioconjugation: synthesis and preliminary evaluation with amphotericin B. Organic & Biomolecular Chemistry 5:9, pages 1339.
Crossref
Crossref
Andreas Zumbuehl, Damien Jeannerat, Scott E. Martin, Marc Sohrmann, Pasquale Stano, Tamas Vigassy, Daniel D. Clark, Stephen L. Hussey, Mathias Peter, Blake R. Peterson, Ernö Pretsch, Peter Walde & Erick M. Carreira. (2004) An Amphotericin B–Fluorescein Conjugate as a Powerful Probe for Biochemical Studies of the Membrane. Angewandte Chemie 116:39, pages 5293-5297.
Crossref
Crossref
Andreas Zumbuehl, Pasquale Stano, Dominik Heer, Peter Walde & Erick M. Carreira. (2004) Amphotericin B as a Potential Probe of the Physical State of Vesicle Membranes. Organic Letters 6:21, pages 3683-3686.
Crossref
Crossref
Jennifer Cannon Sykora, William C. Neely & Vitaly Vodyanoy. (2004) Solvent effects on amphotericin B monolayers. Journal of Colloid and Interface Science 269:2, pages 499-502.
Crossref
Crossref
Hiroshi Fukui, Tomohiro Koike, Akira Saheki, Satoru Sonoke & Junzo Seki. (2003) A novel delivery system for amphotericin B with lipid nano-sphere (LNS®). International Journal of Pharmaceutics 265:1-2, pages 37-45.
Crossref
Crossref
Arnold N. Plotnick. (2000) Lipid-based formulations of amphotericin B. Journal of the American Veterinary Medical Association 216:6, pages 838-841.
Crossref
Crossref
Andrew W. Hing, Jacob Schaefer & George S. Kobayashi. (2000) Deuterium NMR investigation of an amphotericin B derivative in mechanically aligned lipid bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes 1463:2, pages 323-332.
Crossref
Crossref
Olivier CuvillierEric MayhewAndrew S. JanoffSarah Spiegel. (1999) Liposomal ET-18-OCH3 Induces Cytochrome c-Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling. Blood 94:10, pages 3583-3592.
Crossref
Crossref
Jeannine Milhaud & Bernard Michels. (1999) Binding of nystatin and amphotericin B with sterol-free l-dilauroylphosphatidylcholine bilayers resulting in the formation of dichroic lipid superstructures. Chemistry and Physics of Lipids 101:2, pages 223-235.
Crossref
Crossref
M.S. Espuelas, P. Legrand, M. Cheron, G. Barratt, F. Puisieux, J.-Ph. Devissaguet & J.M. Irache. (1998) Interaction of amphotericin B with polymeric colloids. Colloids and Surfaces B: Biointerfaces 11:3, pages 141-151.
Crossref
Crossref
Gert Storm & Daan J.A Crommelin. (1998) Liposomes: quo vadis?. Pharmaceutical Science & Technology Today 1:1, pages 19-31.
Crossref
Crossref
Vincent Beringue, Rémi Demaimay, Karim T. Adjou, Séverine Demart, François Lamoury, Michel Seman, Corinne I. Lasmézas, Jean-Philippe Deslys & Dominique Dormont. 1998. Prions and Brain Diseases in Animals and Humans. Prions and Brain Diseases in Animals and Humans
177
185
.
M.S. Espuelas, P. Legrand, J.M. Irache, C. Gamazo, A.M. Orecchioni, J.-Ph. Devissaguet & P. Ygartua. (1997) Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity. International Journal of Pharmaceutics 158:1, pages 19-27.
Crossref
Crossref
F Gaboriau, M Chéron, C Petit & J Bolard. (1997) Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index. Antimicrobial Agents and Chemotherapy 41:11, pages 2345-2351.
Crossref
Crossref
Robert P Rapp, Paul O Gubbins & Martin E Evans. (2016) Amphotericin B Lipid Complex. Annals of Pharmacotherapy 31:10, pages 1174-1186.
Crossref
Crossref
François Gaboriau, Monique Chéron, Liliane Leroy & Jacques Bolard. (1997) Physico-chemical properties of the heat-induced ‘superaggregates’ of amphotericin B. Biophysical Chemistry 66:1, pages 1-12.
Crossref
Crossref
Jayesh Mehta. (1997) Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?. Leukemia Research 21:3, pages 183-188.
Crossref
Crossref
G. Storm & E. Etten. (1997) Biopharmaceutical aspects of lipid formulations of amphotericin B. European Journal of Clinical Microbiology & Infectious Diseases 16:1, pages 64-73.
Crossref
Crossref
Scott Hartsel & Jacques Bolard. (1996) Amphotericin B: new life for an old drug. Trends in Pharmacological Sciences 17:12, pages 445-449.
Crossref
Crossref
Y. Ridente, J. Aubard & J. Bolard. (1998) Surface-enhanced resonance Raman and circular dichroism spectra of amphotericin B and its methylester derivative in silver colloidal solutions. Biospectroscopy 2:1, pages 1-8.
Crossref
Crossref
Brian D. Wolf & Scott C. Hartsel. (1995) Osmotic stress sensitizes sterol-free phospholipid bilayers to the action of Amphotericin B. Biochimica et Biophysica Acta (BBA) - Biomembranes 1238:2, pages 156-162.
Crossref
Crossref